Expression of p53 and Ki-67 antigen in bone marrow giant proerythroblasts associated with human parvovirus B19 infection

International Journal of Hematology

Volumn 74, Issue 2, 2001, Pages 147-152

  Sadahira, Yoshito ^a   Sugihara, Takashi ^a   Yawata, Yoshihito ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Immunohistochemistry; P53; Parvovirus B19; Red cell aplasia

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADOLESCENT; APOPTOSIS; ARTICLE; BONE MARROW; CASE CONTROL STUDY; CHEMISTRY; ERYTHEMA INFECTIOSUM; ERYTHROBLAST; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PARVOVIRUS; PATHOLOGY; VIROLOGY;

ADOLESCENT; APOPTOSIS; BONE MARROW; CASE-CONTROL STUDIES; ERYTHEMA INFECTIOSUM; ERYTHROBLASTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035434225     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02981997     Document Type: Article

References (22)

1. Torok TJ. Parvovirus B19 and human disease. Adv Intern Med. 1992;37:431-455.
2. Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hemat. 1988;25:159-172.
3. Morey AL, Ferguson DJP, Fleming K A. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis. J Pathol. 1993;169:213-220.
4. Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol. 1998;72:3018-3028.
5. Sol N, Le Junter J, Vassias I, et al. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol. 1999;73:8762-8770.
6. Sadahira Y, Yoshimoto S, Manabe T. Parvovirus B19-associated transient pure red cell aplasia with lymphadenopathy: a case report. Pathol Int. 1998;48:829-833.
7. Takahashi Y, Murai C, Shibata S, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci U S A. 1998;95:8227-8232.
8. Soligo D, Delia D, Oriani A, et al. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. Leukemia. 1991;5:1026-1030.
9. Sadahira Y, Kanzaki A, Wada H, Yawata Y. Immunohistochemical identification of erythroid precursors in paraffin-embedded bone marrow sections: spectrin is a superior marker to glycophorin. J Clin Pathol. 1999;52:919-921.
10. Okubo Y, Daniels GL, Parsons SF, et al Japanese family with two sisters apparently homozygous for Mk. Vox Sang. 1988;54:107-111.
11. Czerwinski M, Wasniowska K, Steuden I, Duk M, Wiedlocha A, Lisowska E. Degradation of the human erythrocyte membrane band-3 studied with monoclonal antibody directed against an epitope on the cytoplasmic fragment of band-3. Eur J Biochem. 1988; 174:647-654.
12. Elghetany MT, Vyas S, Yuoh G. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia. Ann Hematol. 1998;77:261-264.
13. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of BcI-2. Am J Pathol. 1994;145:1323-1336.
14. Krajewska M, Wang HG, Krajewski S, et al. Immunohistochemical analysis of in vivo pattern of expression of CPP32 (caspase-3), a cell death protease. Cancer Res. 1997;57:1605-1613.
15. Urase K, Fujita E, Miho Y, et al. Detection of activated caspase-3 (CPP32) in the vertebrate nervous system during development by a cleavage site-directed antiserum. Brain Res Dev Brain Res. 1998; 111:77-87.
16. Delia D, Aiello A, Soligo D, et al. Bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood. 1992;79: 1291-1298.
17. Motoyama N, Kimura T, Takahashi T, Watanabe T, Nakano T. Bcl-X prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. J Exp Med. 1999;189:1691-1698.
18. Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 1995;146:1309-19
19. Taniguchi T, Endo H, Chikatsu N, et al. Expression of p21Cipl/ Waf1/Sdi1 and p27Kip1 cyclin-dependent kinase inhibitors during human hematopoiesis. Blood. 1999;93:4167-4173.
20. Budke H, Orazi A, Neiman RS, et al. Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA. Mod Pathol. 1994;7:860-866.
21. Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase activation during apoptosis. Ann Rev Cell Dev Biol. 1999;15:269-290.
22. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.